Tag: chief scientific officer
May 8, 2018
New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences
Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm:ATORX), a... May 7, 2018
International Stem Cell Corporation Granted Key Patent in US
International Stem Cell Corporation (OTCQB:ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that... May 4, 2018
Tetra Bio-Pharma Will Distribute PPP001 in Portugal
Tetra Bio-Pharma announced a binding term sheet for the marketing and distribution of its lead candidate PPP001, a smokable cannabis...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ. April 26, 2018
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly
Achaogen (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that it has... April 19, 2018
Hemostemix Announces US FDA Clinical Trial Approval
Hemostemix (TSXV:HEM), a clinical-stage, autologous cell-therapy company, is pleased to announce that the United States Food and Drug Administration has raised... April 19, 2018